$PVLA Cashflow Statement | Understand Stock

$PVLA

$126.23 +$1.13 (0.9%) Close

$PVLA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net Loss
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization
Right-of-use asset amortization
Depreciation and amortization (accretion)
Right-of-use asset (accretion) amortization
Non-cash interest expense - royalty agreement
Non-cash interest expense - convertible notes
Change in fair value of derivative liabilities - royalty agreement
Change in fair value of derivative liabilities - contingent value right liability
Change in fair value of convertible notes payable
Gain on extinguishment - royalty agreement
Stock-based compensation
Asset impairment
Realized investment gains
Other non-cash transactions
Realized investment gain/loss
Deferred tax expense
Foreign currency re-measurement loss
Non-cash lease operating expense
Costs to issue convertible notes charged to expense
Costs to issue convertible notes
Change in operating assets and liabilities:
Accounts receivable
German research and development tax credit receivable
Prepaid expenses and other current assets
Deferred revenue
Account payable
Accrued expenses and other current liabilities
Lease liabilities
Lease liability, prior to operating lease termination
Change in lease liability due to termination of operating lease

Net cash used in operating activities
Purchases of property and equipment
Proceeds from maturity of investments
Purchases of investments
Net cash provided by (used in) investing activities
Cash flows from financing activities
Cash acquired from Reverse Merger transaction
Payment of transaction costs in connection with Reverse Merger
Proceeds from PIPE Financing
Payments of transaction costs associated with PIPE Financing
Proceeds from issuance of convertible notes
Payment of transaction costs to issue convertible notes
Proceeds from exercise of stock options
Proceeds from exercise of warrants
Proceeds from employee stock purchase plan
Proceeds from issuance of common stock resulting from ATM sales, net of $0.7 million and $0.3 million in transaction costs, respectively
Proceeds from amendement to royalty agreement
Deferred equity issuance costs
Net cash (used in) provided by financing activities

Effect of exchange rate change on cash and cash equivalents
Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents at end of year
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
SUPPLEMENTARY DISCLOSURE OF NONCASH FINANCING ACTIVITIES:
Net unrealized gain (loss) on investments
Property and equipment included in accounts payable
Transaction costs related to Reverse Merger included in accounts payable and accrued expenses

Comments